Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Kalincik, Tomas; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Grammond, Pierre; Onofrj, Marco; Lugaresi, Alessandra; ÖZAKBAŞ, SERKAN; Kappos, Ludwig; Kuhle, Jens; TERZİ, MURAT; Lechner-Scott, Jeannette; BOZ, CAVİT; Grand'Maison, Francois; Prevost, Julie; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Trojano, Maria; Bergamaschi, Roberto; Pucci, Eugenio; Turkoglu, Recai; McCombe, Pamela; Van Pesch, Vincent; Van Wijmeersch, Bart; Solaro, Claudio; Ramo-Tello, Cristina; Slee, Mark; Alroughani, Raed; Yamout, Bassem; Shaygannejad, Vahid; Spitaleri, Daniele; Luis Sanchez-Menoyo, Jose; Ampapa, Radek; Hodgkinson, Suzanne; KARABUDAK, RANA; Butler, Ernest; Vucic, Steve; Jokubaitis, Vilija; Spelman, Tim; Butzkueven, Helmut

doi:10.1136/jnnp-2018-319831

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Kalincik T., Havrdova E. K., Horakova D., Izquierdo G., Prat A., Girard M., ...Daha Fazla

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, cilt.90, sa.4, ss.458-468, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 90 Sayı: 4
Basım Tarihi: 2019
Doi Numarası: 10.1136/jnnp-2018-319831
Dergi Adı: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.458-468
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting multiple sclerosis. Direct comparison of their effect on relapse and disability is needed.